Omniab (OABI) Sɔɔtɔ Fɔrɛkɛst
AI forecast: OABI
AI bɔɔ target price fɔ trading day tɛnɛ, week ɛnɛ ɛkpɔ month ɛnɛ ɛkɛ. Change bɔɔ latest price lɛ. Statistical estimates lɛ, not investment advice.
Nɔnyɔ ɔhɛ 6 dɛnɛ a akɛ
Premium shows the AI's price targets for 1 day, 1 week and 1 month for this and every other stock.
Unlock Premium🔒 Nɔ nyɛmɛ nyɛ nyɛmɛ
The forecast track record — every past forecast next to the actual close — is part of Premium.
Unlock PremiumƐŋɛ Nɛ Kɔmpɔni A
OmniAb is a biotechnology company that provides a platform for the discovery of therapeutic antibodies. The company gives pharmaceutical industry partners access to genetically modified animals capable of producing human antibodies, and it offers high-throughput screening technologies and computational platforms for antigen development. OmniAb serves biopharmaceutical companies and research institutions worldwide.
